Global

Oncology Experts

John Timmerman

Associate Professor
Hematology-Oncology
University of California los Angeles
United States of America

Biography

John M Timmerman is an immunologist and oncologist who has served on the UCLA School of Medicine faculty since 2002. He is currently an Associate Professor of Medicine in the Division of Hematology & Oncology. Dr. Timmerman received his undergraduate degrees in biochemistry and physiology from the University of California, Berkeley, and his Master's and M.D. degrees from Boston University. After internship and residency in Internal Medicine at the University of California, San Francisco, he completed postdoctoral fellowship training in Medical Oncology at Stanford University, where he studied immunotherapeutic approaches to lymphoma treatment in both preclinical models and human trials under the mentorship of Dr. Ronald Levy. He is a member of the Tumor Immunology Program within UCLA’s Jonsson Comprehensive Cancer Center, and the UCLA Molecular Biology Institute.

Research Interest

His laboratory research is focused on tumor immunology and cancer immunotherapy, particularly translational research aimed at developing new therapies for lymphomas that incorporate monoclonal antibodies, toll-like receptor agonists, cytokines, therapeutic vaccines, and other targeted agents.

Publications

  • Varghese Bindu, Widman Adam, Do James, Taidi Behnaz, Czerwinski Debra K, Timmerman John, Levy Shoshana, Levy Ronald Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees Blood, 2009; 114(20): 4477-85.

  • Xuan Caiyun, Steward Kristopher K, Timmerman John M, Morrison Sherie L Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma Blood, 2010; 115(14): 2864-71.

  • Olafsen Tove, Sirk Shannon J, Betting David J, Kenanova Vania E, Bauer Karl B, Ladno Waldemar, Raubitschek Andrew A, Timmerman John M, Wu Anna M ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies) Protein engineering, design & selection : PEDS, 2010; 23(4): 243-9.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America